Home LiteratureArticle Details
PMID: 9379142 Published · ppublish English Journal Article Review

Dendritic cells as adjuvants for immune-mediated resistance to tumors.

The Journal of experimental medicine ·Vol. 186 ·No. 8 ·1997-10-20 ·Pages 1183-7

Schuler G, Steinman RM

Abstract

暂无摘要

MeSH Terms
Animals Cell Transplantation/methods Dendritic Cells/transplantation Humans Immunity, Innate Immunotherapy, Adoptive/methods Neoplasms/immunology,therapy Neoplasms, Experimental/immunology,therapy
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Schuler G
Department of Dermatology, University of Erlangen-Nürnberg, Erlangen, Germany.
Steinman R M
References (49)
49 references, click to expand
  1. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells.
    Nature. 1997 Aug 21;388(6644):782-7 PMID: 9285591
  2. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha: II. Functional analysis.
    Blood. 1997 Aug 15;90(4):1458-70 PMID: 9269763
  3. Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases.
    J Exp Med. 1997 Oct 20;186(8):1213-21 PMID: 9334360
  4. Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity.
    J Exp Med. 1997 Oct 20;186(8):1247-56 PMID: 9334364
  5. Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope.
    J Exp Med. 1997 Nov 3;186(9):1481-6 PMID: 9348305
  6. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.
    Science. 1991 Dec 13;254(5038):1643-7 PMID: 1840703
  7. Identification of proliferating dendritic cell precursors in mouse blood.
    J Exp Med. 1992 May 1;175(5):1157-67 PMID: 1569392
  8. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells.
    Nature. 1992 Nov 19;360(6401):258-61 PMID: 1279441
  9. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.
    J Exp Med. 1992 Dec 1;176(6):1693-702 PMID: 1460426
  10. Production of IL-10 by melanoma cells: examination of its role in immunosuppression mediated by melanoma.
    Int J Cancer. 1994 Mar 1;56(5):755-60 PMID: 8314354
  11. Tumor antigens recognized by T lymphocytes.
    Annu Rev Immunol. 1994;12:337-65 PMID: 8011285
  12. Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells.
    J Clin Invest. 1994 Aug;94(2):797-807 PMID: 8040335
  13. Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor.
    Int J Cancer. 1994 Aug 1;58(3):460-4 PMID: 8050828
  14. Elevated serum levels of interleukin-10 in patients with metastatic malignant melanoma.
    Melanoma Res. 1995 Feb;5(1):67-8 PMID: 7734958
  15. Expansion of immunostimulatory dendritic cells among the myeloid progeny of human CD34+ bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-alpha.
    J Immunol. 1995 Jun 1;154(11):5851-61 PMID: 7538534
  16. Fibroblasts as efficient antigen-presenting cells in lymphoid organs.
    Science. 1995 Jun 2;268(5215):1343-7 PMID: 7761853
  17. Massive ex vivo generation of functional dendritic cells from mobilized CD34+ blood progenitors for anticancer therapy.
    Exp Hematol. 1995 Dec;23(14):1463-71 PMID: 8542932
  18. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells.
    Nat Med. 1996 Jan;2(1):52-8 PMID: 8564842
  19. Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity.
    J Exp Med. 1996 Jan 1;183(1):7-11 PMID: 8551246
  20. Generation of human dendritic cells/Langerhans cells from circulating CD34+ hematopoietic progenitor cells.
    Blood. 1996 Feb 15;87(4):1292-302 PMID: 8608217
  21. New insights into the mobilization and phagocytic activity of dendritic cells.
    J Exp Med. 1996 Apr 1;183(4):1287-92 PMID: 8666885
  22. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis.
    J Exp Med. 1996 Apr 1;183(4):1789-96 PMID: 8666935
  23. TGF-beta 1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors.
    J Immunol. 1996 Aug 15;157(4):1499-507 PMID: 8759731
  24. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo.
    J Exp Med. 1996 Aug 1;184(2):465-72 PMID: 8760800
  25. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha.
    J Exp Med. 1996 Aug 1;184(2):695-706 PMID: 8760823
  26. Phenotypic analysis of antigen-specific T lymphocytes.
    Science. 1996 Oct 4;274(5284):94-6 PMID: 8810254
  27. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells.
    Nat Med. 1996 Oct;2(10):1096-103 PMID: 8837607
  28. In vitro differentiation of CD34+ hematopoietic progenitor cells toward distinct dendritic cell subsets of the birbeck granule and MIIC-positive Langerhans cell and the interdigitating dendritic cell type.
    Blood. 1996 Oct 1;88(7):2541-8 PMID: 8839846
  29. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood.
    J Immunol Methods. 1996 Sep 27;196(2):121-35 PMID: 8841451
  30. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability.
    J Immunol Methods. 1996 Sep 27;196(2):137-51 PMID: 8841452
  31. Identification of the genes encoding cancer antigens: implications for cancer immunotherapy.
    Adv Cancer Res. 1996;70:145-77 PMID: 8902056
  32. A novel migration pathway for rat dendritic cells from the blood: hepatic sinusoids-lymph translocation.
    J Exp Med. 1997 Feb 17;185(4):777-84 PMID: 9034155
  33. Origin, maturation and antigen presenting function of dendritic cells.
    Curr Opin Immunol. 1997 Feb;9(1):10-6 PMID: 9039784
  34. Dendritic cells: from ignored cells to major players in T-cell-mediated immunity.
    Int Arch Allergy Immunol. 1997 Apr;112(4):317-22 PMID: 9104785
  35. Immunoselection in vivo: independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma.
    Int J Cancer. 1997 Apr 10;71(2):142-7 PMID: 9139833
  36. Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells.
    Nat Med. 1997 May;3(5):558-61 PMID: 9142127
  37. Capture and processing of exogenous antigens for presentation on MHC molecules.
    Annu Rev Immunol. 1997;15:821-50 PMID: 9143708
  38. Role of Fas ligand (CD95L) in immune escape: the tumor cell strikes back.
    J Immunol. 1997 May 15;158(10):4521-4 PMID: 9144461
  39. The use of computer-assisted video image analysis for the quantification of CD8+ T lymphocytes producing tumor necrosis factor alpha spots in response to peptide antigens.
    J Immunol Methods. 1997 Apr 25;203(2):141-52 PMID: 9149807
  40. Flt3 ligand induces tumor regression and antitumor immune responses in vivo.
    Nat Med. 1997 Jun;3(6):625-31 PMID: 9176488
  41. In vivo detection of dendritic cell antigen presentation to CD4(+) T cells.
    J Exp Med. 1997 Jun 16;185(12):2133-41 PMID: 9182685
  42. TAP off--tumors on.
    Immunol Today. 1997 Jun;18(6):292-9 PMID: 9190116
  43. Functions of CD40 on B cells, dendritic cells and other cells.
    Curr Opin Immunol. 1997 Jun;9(3):330-7 PMID: 9203418
  44. Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody.
    Immunity. 1997 Jun;6(6):715-26 PMID: 9208844
  45. Characterization and quantitation of peptide-MHC complexes produced from hen egg lysozyme using a monoclonal antibody.
    Immunity. 1997 Jun;6(6):727-38 PMID: 9208845
  46. Antigenic cancer cells grow progressively in immune hosts without evidence for T cell exhaustion or systemic anergy.
    J Exp Med. 1997 Jul 21;186(2):229-38 PMID: 9221752
  47. Rat spleen dendritic cells express natural killer cell receptor protein 1 (NKR-P1) and have cytotoxic activity to select targets via a Ca2+-dependent mechanism.
    J Exp Med. 1997 Aug 4;186(3):467-72 PMID: 9236200
  48. Antisense targeting of basic fibroblast growth factor and fibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth.
    Nat Med. 1997 Aug;3(8):887-93 PMID: 9256280
  49. Developmental regulation of MHC class II transport in mouse dendritic cells.
    Nature. 1997 Aug 21;388(6644):787-92 PMID: 9285592
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
DOI
10.1084/jem.186.8.1183
Published
1997-10-20
Pages
1183-7
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2199101
Subset
IM
External Links
PubMed source DOI: 10.1084/jem.186.8.1183 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2